230 related articles for article (PubMed ID: 34640387)
1. Towards a Consensus on Alzheimer's Disease Comorbidity?
Avitan I; Halperin Y; Saha T; Bloch N; Atrahimovich D; Polis B; Samson AO; Braitbard O
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640387
[TBL] [Abstract][Full Text] [Related]
2. Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea.
Luyster FS; Kip KE; Buysse DJ; Aiyer AN; Reis SE; Strollo PJ
Sleep; 2014 Mar; 37(3):593-600. PubMed ID: 24587583
[TBL] [Abstract][Full Text] [Related]
3. The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease.
Ravikumar M; Mohan S; Velpandian C
Curr Drug Saf; 2023; 18(3):284-296. PubMed ID: 35585820
[TBL] [Abstract][Full Text] [Related]
4. Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
Qureshi ZP; Thiel E; Nelson J; Khandker R
J Alzheimers Dis; 2021; 83(4):1679-1690. PubMed ID: 34420974
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer's Disease.
Sultana MA; Hia RA; Akinsiku O; Hegde V
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508448
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease.
Wu JJ; Zhang L; Liu D; Xia J; Yang Y; Tang F; Chen L; Ao H; Peng C
J Ethnopharmacol; 2024 Jan; 318(Pt B):116955. PubMed ID: 37536646
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in sleep apnea and comorbid neurodegenerative diseases.
Snyder B; Cunningham RL
Steroids; 2018 May; 133():28-33. PubMed ID: 29258810
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Disease Comorbidities in Alzheimer's Disease.
Santiago JA; Potashkin JA
Front Aging Neurosci; 2021; 13():631770. PubMed ID: 33643025
[TBL] [Abstract][Full Text] [Related]
9. Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation.
Leyane TS; Jere SW; Houreld NN
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806275
[TBL] [Abstract][Full Text] [Related]
10. Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.
Manukhina EB; Downey HF; Shi X; Mallet RT
Exp Biol Med (Maywood); 2016 Jun; 241(12):1351-63. PubMed ID: 27190276
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease.
Tortajada-Soler M; Sánchez-Valdeón L; Blanco-Nistal M; Benítez-Andrades JA; Liébana-Presa C; Bayón-Darkistade E
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32414124
[No Abstract] [Full Text] [Related]
12. Frailty Syndrome and Oxidative Stress as Possible Links Between Age-Related Hearing Loss and Alzheimer's Disease.
Alvarado JC; Fuentes-Santamaría V; Juiz JM
Front Neurosci; 2021; 15():816300. PubMed ID: 35115905
[TBL] [Abstract][Full Text] [Related]
13. Insomnia and obstructive sleep apnea as potential triggers of dementia: is personalized prediction and prevention of the pathological cascade applicable?
Kitamura T; Miyazaki S; Sulaiman HB; Akaike R; Ito Y; Suzuki H
EPMA J; 2020 Sep; 11(3):355-365. PubMed ID: 32849926
[TBL] [Abstract][Full Text] [Related]
14. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
15. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
Kang S; Lee YH; Lee JE
Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
[TBL] [Abstract][Full Text] [Related]
16. White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model.
Ivanova N; Liu Q; Agca C; Agca Y; Noble EG; Whitehead SN; Cechetto DF
J Neuroinflammation; 2020 Jan; 17(1):29. PubMed ID: 31964387
[TBL] [Abstract][Full Text] [Related]
17. Trends of mitochondrial changes in AD: a bibliometric study.
Song R; Guo Y; Fu Y; Ren H; Wang H; Yan H; Ge Y
Front Aging Neurosci; 2023; 15():1136400. PubMed ID: 37261264
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of
Novotni G; Jakimovska M; Plaseska-Karanfilska D; Tanovska N; Kuzmanovski I; Aleksovski V; Karanfilovik K; Baneva-Dolnenec N; Stankovic M; Milutinovik M; Iloski S; Isjanovska R; Blazevska-Stoilkovska B; Duma A; Novotni A
Open Access Maced J Med Sci; 2019 Feb; 7(4):516-520. PubMed ID: 30894904
[TBL] [Abstract][Full Text] [Related]
19. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
20. Biological and disease hallmarks of Alzheimer's disease defined by Alzheimer's disease genes.
Murakami S; Lacayo P
Front Aging Neurosci; 2022; 14():996030. PubMed ID: 36437990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
